Latest Cyclopropanes Stories
Compared to Clopidogrel, Prasugrel Did Not Have a Higher Risk of Bleeding at 90 Days SAN DIEGO, May 8, 2015 /PRNewswire/ -- Prasugrel (Effient®) is more likely to be given to lower-risk
First-ever meta-analysis of pitavastatin confirms no significant adverse effect compared with placebo or other statins on fasting blood glucose, HbA1c, or new-onset diabetes MONTGOMERY, Ala.,
ReportsnReports.com adds “Global and Chinese Pitavastatin calcium Industry, 2009-2019 Market Research Report” to its store. Dallas, TX (PRWEB) February 23,
NEW YORK, Jan. 5, 2015 /PRNewswire/ -- Exelixis, Inc. (NASDAQ: EXEL) is a biotechnology company that develops and markets treatments for cancer.
LONDON and PITTSBURGH, Dec. 4, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S.
PITTSBURGH and LONDON, Dec. 4, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S.
WHIPPANY, N.J., Nov. 24, 2014 /PRNewswire/ -- The U.S.
This innovative combination of drugs could become the treatment of choice in those cases BARCELONA, Spain, September 29, 2014 /PRNewswire/ -- Laboratorios SALVAT
DALLAS, September 7, 2014 /PRNewswire/ -- MarketOptimizer.org adds "Acute Coronary Syndrome - US Drug Forecast and Market Analysis to 2023", a new research report to its
LifeScienceIndustryResearch.com adds Latest Report on “Market Research Report on Global and Chinese Ciprofloxacin HCl Industry, 2009-2019” to its store.
- The parings of haberdine; also, any kind of fragments.